Iron oxide nanoparticle-induced epidermal growth factor receptor expression in human stem cells for tumor therapy

ACS Nano

Volumn 5, Issue 12, 2011, Pages 9807-9816

  Chung, Tsai Hua ^a,b   Hsiao, Jong Kai ^c   Hsu, Szu Chun ^b   Yao, Ming ^b   Chen, Yao Chang ^b   Wang, Shih Wei ^d   Kuo, Mark Yen Ping ^b   Yang, Chung Shi ^a   Huang, Dong Ming ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c TZU CHI UNIVERSITY   (Taiwan)

^d MACKAY MEDICAL COLLEGE   (Taiwan)

Author keywords

cancer therapy; iron oxide nanoparticle; mesenchymal stem cell; MRI; tumor tropism

Indexed keywords

ANGIOGENESIS; ANTI-TUMOR ACTIVITIES; CANCER THERAPY; CELL-BASED THERAPY; EPIDERMAL GROWTH FACTOR RECEPTORS; HUMAN MESENCHYMAL STEM CELLS (HMSCS); IRON OXIDE NANOPARTICLE; MESENCHYMAL STEM CELL; OVER-EXPRESSION; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES; TUMOR GROWTH; TUMOR PROGRESSIONS; TUMOR THERAPY;

CELL CULTURE; IRON; MAGNETIC RESONANCE IMAGING; NANOMAGNETICS; NANOPARTICLES; PEPTIDES; STEM CELLS; SUPERPARAMAGNETISM; TUMORS;

IRON OXIDES;

CONTRAST MEDIUM; DEXTRAN; EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; FERUMOXTRAN-10; MAGNETITE NANOPARTICLE; NANOPARTICLE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL; ARTICLE; CELL SURVIVAL; COLON TUMOR; CYTOLOGY; DRUG EFFECT; HUMAN; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; METHODOLOGY; MOUSE; MULTIMODALITY CANCER THERAPY; TREATMENT OUTCOME; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; COLONIC NEOPLASMS; COMBINED MODALITY THERAPY; CONTRAST MEDIA; DEXTRANS; HUMANS; MAGNETITE NANOPARTICLES; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; NANOPARTICLES; RECEPTOR, EPIDERMAL GROWTH FACTOR; TREATMENT OUTCOME;

EID: 84555163667     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn2033902     Document Type: Article

References (22)

1. Kostura, H.; Kraitchman, D. L.; Mackay, A. M.; Pittenger, M. F.; Bulte, J. W. Feridex Labeling of Mesenchymal Stem Cells Inhibits Chondrogenesis but Not Adipogenesis or Osteogenesis NMR Biomed. 2004, 17, 513-517 (Pubitemid 39549429)
2. Arbab, A. S.; Yocum, G. T.; Rad, A. M.; Khakoo, A. Y.; Fellowes, V.; Read, E. J.; Frank, J. A. Labeling of Cells with Ferumoxides-Protamine Sulfate Complexes Does Not Inhibit Function or Differentiation Capacity of Hematopoietic or Mesenchymal Stem Cells NMR Biomed. 2005, 18, 553-559 (Pubitemid 43013896)
3. Huang, D. M.; Hsiao, J. K.; Chen, Y. C.; Chien, L. Y.; Yao, M.; Chen, Y. K.; Ko, B. S.; Hsu, S. C.; Tai, L. A.; Cheng, H. Y. et al. The Promotion of Human Mesenchymal Stem Cell Proliferation by Superparamagnetic Iron Oxide Nanoparticles Biomaterials 2009, 30, 3645-3651
4. Chen, Y. C.; Hsiao, J. K.; Liu, H. M.; Lai, I. Y.; Yao, M.; Hsu, S. C.; Ko, B. S.; Chen, Y. C.; Yang, C. S.; Huang, D. M. The Inhibitory Effect of Superparamagnetic Iron Oxide Nanoparticle (Ferucarbotran) on Osteogenic Differentiation and Its Signaling Mechanism in Human Mesenchymal Stem Cells Toxicol. Appl. Pharmacol. 2010, 245, 272-279
5. Chien, L. Y.; Hsiao, J. K.; Hsu, S. C.; Yao, M.; Lu, C. W.; Liu, H. M.; Chen, Y. C.; Yang, C. S.; Huang, D. M. In Vivo Magnetic Resonance Imaging of Cell Tropsim, Trafficking Mechanism, and Therapeutic Impact of Human Mesenchymal Stem Cells in a Murine Glioma Model Biomaterials 2011, 32, 3275-3284
6. Yang, C. Y.; Hsiao, J. K.; Tai, M. F.; Chen, S. T.; Cheng, H. Y.; Wang, J. L.; Liu, H. M. Direct Labelling of hMSC with SPIO: The Long-Term Influence on Toxicity, Chondrogenic Differentiation Capacity, and Intracellular Distribution Mol. Imaging Biol. 2011, 13, 443-451
7. Kim, H. S.; Oh, S. Y.; Joo, H. J.; Son, K. R.; Song, I. C.; Moon, W. K. The Effects of Clinically Used MRI Contrast Agents on the Biological Properties of Human Mesenchymal Stem Cells NMR Biomed. 2010, 23, 514-522
8. Balakumaran, A.; Pawelczyk, E.; Ren, J.; Sworder, B.; Chaudhry, A.; Sabatino, M.; Stroncek, D.; Frank, J. A.; Robey, P. G. Superparamagnetic Iron Oxide Nanoparticles Labelling of Bone Marrow Stromal (Mesenchymal) Cells Does Not Affect Their "Stemness" PLoS ONE 2010, 5, e11462
9. Woodburn, J. R. The Epidermal Growth Factor Receptor and Its Inhibition in Cancer Therapy Pharmacol. Ther. 1999, 82, 241-250 (Pubitemid 29255919)
10. Sato, H.; Kuwashima, N.; Sakaida, T.; Hatano, M.; Dusak, J. E.; Fellows-Mayle, W. K.; Papworth, G. D.; Watkins, S. C.; Gambotto, A.; Pollack, I. F. et al. Epidermal Growth Factor Receptor-Transfected Bone Marrow Stromal Cells Exhibit Enhanced Migratory Response and Therapeutic Potential Against Murine Tumors Cancer Gene Ther. 2005, 12, 757-768 (Pubitemid 41208615)
11. Nakamura, K.; Ito, Y.; Kawano, Y.; Kurozumi, K.; Kobune, M.; Tsuda, H.; Bizen, A.; Honmou, O.; Niitsu, Y.; Hamada, H. Antitumor Effect of Genetically Engineered Mesenchymal Stem Cells in a Rat Glioma Model Gene Ther. 2004, 11, 1155-1164 (Pubitemid 39117311)
12. Khakoo, A. Y.; Pati, S.; Anderson, S. A.; Reid, W.; Elshal, M. F.; Rovira, I. I.; Nguyen, A. T.; Malide, D.; Combs, C. A.; Hall, G. et al. Human Mesenchymal Stem Cells Exert Potent Antitumorigenic Effects in A Model of Kaposis Sarcoma J. Exp. Med. 2006, 230, 1235-1247 (Pubitemid 43736593)
13. Qiao, L.; Xu, Z.; Zhao, T.; Zhao, Z.; Shi, M.; Zhao, R. C.; Ye, L.; Zhang, X. Suppression of Tumorigenesis by Human Mesenchymal Stem Cells in a Hepatoma Model Cell Res. 2008, 18, 500-507 (Pubitemid 351498857)
14. Ruck, A.; Paulie, S. The Epidermal Growth Factor Receptor Is Involved in Autocrine Growth of Human Bladder Carcinoma Cell Lines Anticancer Res. 1997, 17, 1925-1931 (Pubitemid 27320928)
15. Yamamoto, N.; Mammadova, G.; Song, R. X.; Fukami, Y.; Sato, K. Tyrosine Phosphorylation of p145met Mediated by EGFR and Src Is Required for Serum-Independent Survival of Human Bladder Carcinoma Cells J. Cell Sci. 2006, 119, 4623-4633 (Pubitemid 44964259)
16. Ruan, W. J.; Lai, M. D. Autocrine Stimulation in Colorectal Carcinoma (CRC): Positive Autocrine Loops in Human Colorectal Carcinoma and Applicable Significance of Blocking the Loops Med. Oncol. 2004, 21, 1-8
17. Herbst, R. S.; Johnson, D. H.; Mininberg, E.; Carbone, D. P.; Henderson, T.; Kim, E. S.; Blumenschein, G., Jr.; Lee, J. J.; liu, D. D.; Truong, M. T. et al. Phase I/II Trial Evaluating the Anti-Vascular Endothelial Growth Factor Monoclonal Antibody Bevacizumab in Combination with the HER-1/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib for Patients with Recurrent Non-Small-Cell Lung Cancer J. Clin. Oncol. 2005, 23, 2544-2555
18. Niu, G.; Wright, K. L.; Huang, M.; Song, L.; Haura, E.; Turkson, J.; Zhang, S.; Wang, T.; Sinibaldi, D.; Coppola, D. et al. Constitutive Stat3 Activity Up-Regulates VEGF Expression and Tumor Angiogenesis Oncogene 2002, 21, 2000-2008 (Pubitemid 34270888)
19. Zhong, H.; Chiles, K.; Feldser, D.; Laughner, E.; Hanrahan, C.; Georgescu, M. M.; Simons, J. W.; Semenza, G. L. Modulation of Hypoxia-Inducible Factor 1Alpha Expression by the Epidermal Growth Factor/Phosphatidylinositol 3-Kinase/PTEN/AKT/FRAP Pathway in Human Prostate Cancer Cells: Implications for Tumor Angiogenesis and Therapeutics Cancer Res. 2000, 60, 1541-1545 (Pubitemid 30183422)
20. Ciardiello, F.; Tortora, G. A Novel Approach in The Treatment of Cancer: Targeting The Epidermal Growth Factor Receptor Clin. Cancer Res. 2001, 7, 2958-2970 (Pubitemid 32963812)
21. Pore, N.; Jiang, Z.; Gupta, A.; Cerniglia, G.; Kao, G. D.; Maity, A. EGFR Tyrosine Kinase Inhibitors Decrease VEGF Expression by Hypoxia-Inducible Factor (HIF)-1-Independent and HIF-1-Dependent Mechanisms Cancer Res. 2006, 66, 3197-3204
22. Huang, D. M.; Hung, Y.; Ko, B. S.; Hsu, S. C.; Chen, W. H.; Chien, C. L.; Tsai, C. P.; Kuo, C. T.; Kang, J. C.; Yang, C. S. et al. Highly Efficient Cellular Labeling of Mesoporous Nanoparticles in Human Mesenchymal Stem Cells: Implication for Stem Cell Tracking FASEB J. 2005, 19, 2014-2016 (Pubitemid 41759749)